Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


03.09.2018

1 Ann Neurol
1 Brain
1 J Neurol Sci
2 Lancet Child Adolesc Health
3 Mult Scler
1 N Engl J Med
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. WOLINSKY JS, Montalban X, Hauser SL, Giovannoni G, et al
    Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
    Ann Neurol. 2018 Aug 29. doi: 10.1002/ana.25313.
    PubMed     Text format     Abstract available


    Brain

  2. EIJLERS AJC, van Geest Q, Dekker I, Steenwijk MD, et al
    Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Brain. 2018;141:2605-2618.
    PubMed     Text format     Abstract available


    J Neurol Sci

  3. JAKIMOVSKI D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, et al
    Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
    J Neurol Sci. 2018;393:128-134.
    PubMed     Text format     Abstract available


    Lancet Child Adolesc Health

  4. FADDA G, Brown RA, Longoni G, Castro DA, et al
    MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
    Lancet Child Adolesc Health. 2018;2:191-204.
    PubMed     Text format     Abstract available

  5. HINTZEN RQ
    Paediatric multiple sclerosis: early diagnosis as a first step.
    Lancet Child Adolesc Health. 2018;2:161-162.
    PubMed     Text format    


    Mult Scler

  6. O'MAHONY J, Marrie RA, Laporte A, Bar-Or A, et al
    Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.
    Mult Scler. 2018 Aug 30:1352458518796676. doi: 10.1177/1352458518796676.
    PubMed     Text format     Abstract available

  7. VAN MUNSTER CE, D'Souza M, Steinheimer S, Kamm CP, et al
    Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis.
    Mult Scler. 2018 Aug 31:1352458518796690. doi: 10.1177/1352458518796690.
    PubMed     Text format     Abstract available

  8. VAN ROSSUM JA, Killestein J, Villar LM, Riskind PN, et al
    gMS-Classifier1 does not predict disability progression in multiple sclerosis.
    Mult Scler. 2018 Aug 31:1352458518798048. doi: 10.1177/1352458518798048.
    PubMed     Text format    


    N Engl J Med

  9. FOX RJ, Coffey CS, Conwit R, Cudkowicz ME, et al
    Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    N Engl J Med. 2018;379:846-855.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  10. KARIM H, Kim SH, Lapato AS, Yasui N, et al
    Increase in chemokine CXCL1 by ERbeta ligand treatment is a key mediator in promoting axon myelination.
    Proc Natl Acad Sci U S A. 2018;115:6291-6296.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: